Cargando…

CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis

BACKGROUND: Cysteine and Glycine Rich Protein 1 (CSRP1) belongs to the cysteine-rich protein family, which contains a unique double-zinc finger motif and is important for development and cellular differentiation. Abnormal expression of CSRP1 was reported within several malignancies such as prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Senlong, Zhao, Haifeng, Meng, Hongjie, Shi, Shengguang, Cao, Shenghui, Bian, Tianhua, Ruan, Canping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129416/ https://www.ncbi.nlm.nih.gov/pubmed/37113556 http://dx.doi.org/10.1155/2023/8586507

Ejemplares similares

miR‐548d‐3p inhibits the invasion and migration of gastric cancer cells by targeting GKN1
por: Yu, Senlong, et al.
Publicado: (2022)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Muscle Lim Protein (MLP)/CSRP3 at the crossroad between mechanotransduction and autophagy
por: Rashid, M M, et al.
Publicado: (2015)

Muscle LIM protein/CSRP3: a mechanosensor with a role in autophagy
por: Rashid, M M, et al.
Publicado: (2015)

The CSRP2BP histone acetyltransferase drives smooth muscle gene expression
por: Ma, Yanlin, et al.
Publicado: (2017)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

A Novel Role for CSRP1 in a Lebanese Family with Congenital Cardiac Defects
por: Kamar, Amina, et al.
Publicado: (2017)

Guanylate‐binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients
por: Wan, Quanchao, et al.
Publicado: (2020)

Increased Kremen2 predicts worse prognosis in colon cancer
por: Long, Junxian, et al.
Publicado: (2023)

The Autophagy Regulatory Molecule CSRP3 Interacts with LC3 and Protects Against Muscular Dystrophy
por: Cui, Can, et al.
Publicado: (2020)

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
por: Chen, Cheng, et al.
Publicado: (2020)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

LIM domain-wide comprehensive virtual mutagenesis provides structural rationale for cardiomyopathy mutations in CSRP3
por: Chauhan, Pankaj Kumar, et al.
Publicado: (2022)

CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukemia
por: Cao, Lei-Ming, et al.
Publicado: (2023)

Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis
por: Xia, Yan, et al.
Publicado: (2018)

Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome
por: Li, Dan, et al.
Publicado: (2021)

Author Correction: LIM domain-wide comprehensive virtual mutagenesis provides structural rationale for cardiomyopathy mutations in CSRP3
por: Chauhan, Pankaj Kumar, et al.
Publicado: (2022)

Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma
por: Wang, Jue, et al.
Publicado: (2016)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

Histone acetyltransferase CSRP2BP promotes the epithelial–mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin
por: Yang, Xiaohui, et al.
Publicado: (2023)

Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth
por: Feng, Jingyu, et al.
Publicado: (2022)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
por: Meng, Chuang, et al.
Publicado: (2022)

INSC Is a Prognosis-Associated Biomarker Involved in Tumor Immune Infiltration in Colon Adenocarcinoma
por: Zhaoran, Su, et al.
Publicado: (2022)

LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
por: Huang, Xuanmei, et al.
Publicado: (2021)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma
por: Xiao, Yong, et al.
Publicado: (2021)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Candida airway colonization is associated with worse outcomes
por: Delisle, M, et al.
Publicado: (2007)

Medullary carcinoma of the colon: an adenocarcinoma with better prognosis
por: Kasapidis, Panagiotis, et al.
Publicado: (2015)

Comprehensive Proteomic Analysis of Colon Cancer Tissue Revealed the Reason for the Worse Prognosis of Right-Sided Colon Cancer and Mucinous Colon Cancer at the Protein Level
por: Chen, Yanyu, et al.
Publicado: (2021)

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
por: Ma, Rong, et al.
Publicado: (2019)

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients
por: Zhu, Weiwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pp6cr3apv4tnpksa9825p3j2me